Manulife (Manufacturers Life Insurance)’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $593K | Buy |
46,257
+309
| +0.7% | +$3.94K | ﹤0.01% | 2080 |
|
|
2025
Q4 | $413K | Sell |
45,948
-255
| -0.6% | -$3.51K | ﹤0.01% | 2257 |
|
|
2025
Q3 | $798K | Buy |
46,203
+9,147
| +25% | +$113K | ﹤0.01% | 1982 |
|
|
2025
Q2 | $348K | Buy |
37,056
+637
| +2% | +$5.23K | ﹤0.01% | 2322 |
|
|
2025
Q1 | $259K | Sell |
36,419
-11,496
| -24% | -$116K | ﹤0.01% | 2391 |
|
|
2024
Q4 | $559K | Sell |
47,915
-5,630
| -11% | -$87.9K | ﹤0.01% | 2186 |
|
|
2024
Q3 | $1.1M | Sell |
53,545
-647
| -1% | -$14.9K | ﹤0.01% | 1873 |
|
|
2024
Q2 | $1.21M | Sell |
54,192
-11,974
| -18% | -$285K | ﹤0.01% | 1755 |
|
|
2024
Q1 | $1.82M | Buy |
66,166
+2,935
| +5% | +$81.5K | ﹤0.01% | 1551 |
|
|
2023
Q4 | $1.93M | Sell |
63,231
-5,264
| -8% | -$151K | ﹤0.01% | 1478 |
|
|
2023
Q3 | $2.17M | Buy |
68,495
+10,751
| +19% | +$417K | ﹤0.01% | 1412 |
|
|
2023
Q2 | $2.35M | Sell |
57,744
-6,426
| -10% | -$261K | ﹤0.01% | 1365 |
|
|
2023
Q1 | $2.39M | Buy |
64,170
+323
| +0.5% | +$12.7K | ﹤0.01% | 1356 |
|
|
2022
Q4 | $2.24M | Buy |
63,847
+9,696
| +18% | +$461K | ﹤0.01% | 1353 |
|
|
2022
Q3 | $3.01M | Sell |
54,151
-542
| -1% | -$33.6K | ﹤0.01% | 1272 |
|
|
2022
Q2 | $2.85M | Buy |
54,693
+4,893
| +10% | +$248K | ﹤0.01% | 1337 |
|
|
2022
Q1 | $3.61M | Buy |
49,800
+14,781
| +42% | +$1.25M | ﹤0.01% | 1341 |
|
|
2021
Q4 | $4.18K | Buy |
35,019
+215
| +0.6% | +$26.9K | ﹤0.01% | 1320 |
|
|
2021
Q3 | $4.67M | Sell |
34,804
-754
| -2% | -$114K | ﹤0.01% | 1274 |
|
|
2021
Q2 | $5.76M | Buy |
35,558
+4,858
| +16% | +$378K | ﹤0.01% | 1216 |
|
|
2021
Q1 | $2.46M | Buy |
30,700
+718
| +2% | +$48.2K | ﹤0.01% | 1482 |
|
|
2020
Q4 | $1.63M | Buy |
29,982
+1,666
| +6% | +$60.5K | ﹤0.01% | 1603 |
|
|
2020
Q3 | $563K | Buy |
28,316
+1,976
| +8% | +$41.2K | ﹤0.01% | 1946 |
|
|
2020
Q2 | $538K | Buy |
26,340
+976
| +4% | +$16.6K | ﹤0.01% | 1927 |
|
|
2020
Q1 | $310K | Buy |
25,364
+1,426
| +6% | +$19.2K | ﹤0.01% | 2076 |
|
|
2019
Q4 | $351K | Sell |
23,938
-211
| -0.9% | -$2.94K | ﹤0.01% | 2248 |
|
|
2019
Q3 | $322K | Buy |
24,149
+470
| +2% | +$7.49K | ﹤0.01% | 2281 |
|
|
2019
Q2 | $388K | Buy |
23,679
+969
| +4% | +$15.2K | ﹤0.01% | 2197 |
|
|
2019
Q1 | $387K | Buy |
22,710
+1,737
| +8% | +$25.9K | ﹤0.01% | 2190 |
|
|
2018
Q4 | $287K | Sell |
20,973
-1,282
| -6% | -$23.8K | ﹤0.01% | 2180 |
|
|
2018
Q3 | $637K | Sell |
22,255
-2,902
| -12% | -$84.4K | ﹤0.01% | 2109 |
|
|
2018
Q2 | $689K | Buy |
25,157
+11,754
| +88% | +$285K | ﹤0.01% | 2131 |
|
|
2018
Q1 | $283K | Sell |
13,403
-248
| -2% | -$6.1K | ﹤0.01% | 2751 |
|
|
2017
Q4 | $262K | Buy |
13,651
+1,389
| +11% | +$32.1K | ﹤0.01% | 2812 |
|
|
2017
Q3 | $304K | Sell |
12,262
-962
| -7% | -$18.1K | ﹤0.01% | 2640 |
|
|
2017
Q2 | $212K | Buy |
13,224
+10,825
| +451% | +$151K | ﹤0.01% | 2958 |
|
|
2017
Q1 | $33K | Buy |
2,399
+1,376
| +135% | +$18.5K | ﹤0.01% | 3443 |
|
|
2016
Q4 | $13K | Sell |
1,023
-4,637
| -82% | -$69.7K | ﹤0.01% | 3718 |
|
|
2016
Q3 | $96K | Buy |
5,660
+877
| +18% | +$17K | ﹤0.01% | 3220 |
|
|
2016
Q2 | $102K | Buy |
+4,783
| New | +$127K | ﹤0.01% | 3205 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
